Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | difenidol | 10621 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | difenidol | 10621 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | difenidol | 10621 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | difenidol | 10621 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | difenidol | 10621 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | difenidol | 10621 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | 0198306-0000 | None | drug-path |
| Shigellosis | 0 | map05131 | 0198306-0000 | None | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | 0198306-0000 | None | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | 0198306-0000 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | 0198306-0000 | None | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | 0198306-0000 | None | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | 0198306-0000 | None | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | dexamethasone | 5743 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | dexamethasone | 5743 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | dexamethasone | 5743 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | dexamethasone | 5743 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | dexamethasone | 5743 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | betaxolol | 2369 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | betaxolol | 2369 | drug-path |